Effect and safety of Substance P containing moisturizer in xerosis during retinoid treatment
Not Applicable
Recruiting
- Conditions
- Diseases of the skin and subcutaneous tissue
- Registration Number
- KCT0002412
- Lead Sponsor
- Kyung Hee University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1. Those who taking isotretinoin, acitretin, alitretinoin.
2. Those who voluntarily signed the agreement and signed it after hearing enough explanation.
3. Those who can follow up during the test period
Exclusion Criteria
1.If the application is difficult on the application site, hand, face etc.
2.Oral steroid-based medication is needed in the standard treatment.
3.If clobetasol is to be treated at the site of application.
4. Pregnant or lactating women and possibly pregnant women.
5.People who use functional cosmetics or medicines that can affect the test site within 3 months before the start of the study.
6.Those who have been treated on the test site within 6 months prior to the start of the study.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method hydration of skin
- Secondary Outcome Measures
Name Time Method transepidermal water loss